Genomic Vision | GenomeWeb

Genomic Vision

The company attributed the decline to lower revenues from its collaboration with Quest Diagnostics.

Product sales rose nearly 23 percent during the year, but this was offset by a 34 percent dip in revenue from an R&D collaboration with Quest Diagnostics.

The French molecular diagnostics company said almost 95 percent of its revenue during the quarter came from its R&D collaboration with Quest Diagnostics.

The company and the hospital will conduct a clinical study into the detection and prevention of the disease.

Under the arrangement, the partners will use Genomic Vision's molecular combing technology to identify genetic variations underlying different diseases.

A 56 percent increase in revenues from the French molecular diagnostic firm's collaboration with Quest Diagnostics drove up overall revenue growth. 

The firm said the drop in revenues was due to a lack of milestone payments from Quest Diagnostics, which accounted for half of all revenues in the prior-year period.

Through its agreement with Quest Diagnostics, the company plans to launch a BRCA1/2 test, followed by tests for Lynch syndrome and HPV. 

The alliance is developing new optical DNA mapping technologies for diagnostic applications.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.